Abstract
We have analyzed the expression of the anti-apoptotic proteins bcl-2, bcl-xl and that of bax, a pro-apoptotic protein, in human WHO grade II astrocytomas (LGA) and WHO grade IV glioblastoma multiforme (GBM). Tumors were obtained immediately after surgical resection and were analyzed by immunohistochemistry (IHC), laser confocal microscopy (LCM) and immunoblots. Both IHC and immunoblot analysis indicated that the expression of bcl-xl was not significantly different between LGA and GBM. IHC indicated that the expression of bcl-2 was inversely correlated to the grade of the tumors (i.e more cells were bcl-2 positive in LGA than in GBM) while the expression of bax was unaffected by the grade of the tumor. In contrast, immunoblots revealed a parallel increase in the expression of bcl-2 and bax from the low to high grade tumor, suggesting a co-regulation of the expression of these two proteins during tumoral progression. Confocal analyses provide us with another possible level of complexicity in the regulation of apoptosis in these tumors, as these markers exhibited different subcellular localizations: bcl-2 was strictly associated with mitochondria and bcl-xl was present in both cytosolic and mitochondrial compartments while bax was found essentially in the cytosol of the tumoral cells. Taken together, our data suggest that the role of bcl-2 related proteins could be regulated at different levels in human astrocytomas (expression, subcellular localization, antigen exposure...) which should be studied by different techniques.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Blomberg H: Brain Tumors. Acta Oncol 35: 16–21, 1996
Kleishue P, Burger PC, Scheithauer BW: The new WHO classification of brain tumours. Brain Pathol 3: 255–268, 1993
Kleihues P, Ohgaki H: Phenotype vs genotype in the evolution of astrocytic brain tumors. Toxicol Pathol 28: 164–170, 2000
Korsmeyer SJ: BCL-2 gene family and the regulation of programmed cell death. Cancer Res (suppl) 59: 1693s–1700s, 1999
Reed JC: Dysregulation of apoptosis in cancer. J Clin Oncol 17: 2941–2953, 1999
Korsmeyer SJ, Greenberg P: Cancer: tuning in on death programs. Curr Opin in Immunol 10: 543–544, 1998
Soini Y, Pääkkö P, Lehto V-P: Histopathological evaluation of apoptosis in cancer. Am J Pathol 153: 1041–1053, 1998
Ohgaki H, Schauble B, Hausen AZ, Ammon KV, Kleihues P: Genetic alterations associated with the evolution and the progression of astrocytic brain tumours. Virchows Arch 427: 113–118, 1995
Freiss H, Lu Z, Graber HU, Zimmermann A, Adler G, Korc M, Schmid RM, Büchler MW: Bax, but not bcl-2, influences the prognosis of human pancreatic cancer. Gut 43: 414–421, 1998
Krajewska M, Moss SF, Krajewski S, Song K, Holt PR, Reed JC: Elevated expression of Bcl-X and reduced Bak in primary colorectal adenocarcinomas. Cancer Res 56: 2422–2427, 1996a
Krajewska M, Fenoglio-Preiser C, Krajewsky S, Song K, MacDonald J, Stemmerman G, Reed JC: Immunohistochemical analysis of Bcl-2 family proteins in adenocarcinomas of the stomach. Am J Pathol 149: 1449–1457, 1996b
Krajewski S, Krajewska M, Ehrman J, Sikorska M, Lach B, Chatten J, Reed JC: Immunohistochemical analysis of bcl-2, bcl-xl, Mcl-1 and bax in tumors of central and peripheral nervous system origin. Am J Pathol 150: 805–814, 1997
Nakasu S, Nioka H, Nakajima M, Handa J: Bcl-2 protein expression in tumors of the central nervous system. Acta Neuropath (Berlin) 88: 520–526, 1994
Newcomb EA, Bhalla SK, Parrish CL, Hayes RL, Cohen H, Miller DC: Bcl-2 protein expression in astrocytomas in relation to patient survival and p53 gene status. Acta Neuropathol 94: 369–375, 1997
Ellison DW, Steart PV, Gatter KC, Weller RO: Apoptosis in cerebral astrocytic tumours and its relationship to expression of the bcl-2 and p53 proteins. Neuropath Appl Neurobiol 2: 352–361, 1995
Krishna M, Smith TW, Recht LD: Expression of bcl-2 in reactive and neoplastic astrocytes: lack of correlation with presence or degree of malignancy. J Neurosurg 83: 1017–1022, 1995
Rieger L, Weller M, Borneman A, Schabet M, Dichgans J, Meyermann R: Bcl-2 family protein expression in human malignant expression: a clinical-pathological correlative study. J Neurol Sci 155: 68–75, 1998
Hara A, Hirose Y, Yoshimi N, Tanaka T, Mori H: Expression of bax and bcl-2 proteins, regulators of programmed cell death in human brain tumors. J Neurol Res 19: 623–628, 1997
Newcomb EA, Cohen H, Lee SR, Bhalla SK, Bloom J, Hayes RL, Miller DC: Survival of patients with glioblastoma multiforme is not influenced by altered expression of p16, p53, EGFR, MDM-2 or Bcl-2 genes. Brain Pathol 8: 655–667, 1998
Schiffer D, Cavalla P, Migheli A, Giordana MT, Chiado-Piat L: Bcl-2 distribution in neuroepithelial tumors: an immunohistochemical study. J Neuro-Oncol 27: 101–109, 1996
Strik H, Deininger J, Streffer E, Grote J, Wickboldt J, Dichgans M, Weller M, Meyerman R: BCL-2 family protein expression in initial and recurrent glioblastomas: modulation by radiotherapy. J Neurol Neurosurg Psychiatry 67: 763–768, 1999
Alderson LM, Castleberg RL, Harsh GR, Louis DL, Henson JW: Human gliomas with wild-type p53 express bcl-2. Cancer Res 55: 999–10001, 1995
Juin P, Pelletier M, Oliver L, Tremblais K, Grégoire M, Meflah K, Vallette FM: Induction of a caspase-3-like activity by calcium in normal cytosolic extracts triggers nuclear apoptosis in a cell-free system. J Biol Chem 273: 17559–17564, 1998
Wolter KG, Hsu YT, Smith CL, Nechustan A, Xi XG, Youle RJ: Movement of bax from the cytosol to mitochondria during apoptosis. J Cell Biol 139: 1281–1292, 1997
Rampino N, Yamamoto H, Ionov Y, Li Y, Sawai H, Reed JC, Perucho M: Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype. Science 275: 967–969, 1997
Watanabe K, Tachibana O, Yonekawa Y, Kleihues P, Ohgaki H: Role of gemistocytes in astrocytoma progression. Lab Invest 76: 277–284, 1997
Reed JC, Kromer G. Mitochondrial control of cell death. Nature Med 6: 513–519, 2000
Hsu YT, Wolter KG, Youle RJ: Cytosol-to-membrane redistribution of bax and bcl-xl during apoptosis. Proc Natl Acad Sci USA 94: 3668–3672, 1997
Simonian PL, Grillot D, Nunez G: Bcl-2 and bcl-xl can differentially block chemotherapy-induced cell death. Blood 90: 1208–1216, 1997
Merry DE, Korsmeyer SJ: Bcl-2 gene family in the nervous system. Annu Rev Neurosci 2: 245–267, 1997
Vyas S, Javoy-Agid F, Herrero MT, Strada O, Boissiere F, Hibner U, Agid Y: Expression of Bcl-2 in adult human brain regions with special reference to neurodegenerative disorders. J Neurochem 69: 223–223, 1997